Australian patients considering a stem cell injection often find that access at home is restricted to specific TGA-regulated uses or clinical trials. StemCellCure, a trusted stem cell provider in India, works with patients from Sydney, Melbourne, and across Australia to review suitability remotely before treatment in Delhi NCR.
At every stage, our team — led by regenerative medicine specialist Dr. Prashant Tyagi and general physician Dr. B. N. Singh — reviews each patient's medical history, current health status, and diagnostic reports before recommending a treatment plan. This includes a baseline health assessment covering major organ function, since a full health evaluation helps confirm suitability and reduces risk during treatment. For Australia patients specifically, much of this evaluation can begin remotely, based on reports shared in advance, so that a large part of the groundwork is already complete before you book your flight to Delhi NCR. Our approach combines advanced regenerative science with careful, individualised medical oversight, rather than a one-size-fits-all treatment package.
Regenerative treatment options in Australia can be tightly regulated and slow to access for many chronic conditions. Australian patients increasingly explore stem cell injection therapy in India as a quicker, more accessible pathway, working with an established stem cell provider with an international patient track record.
Dr. Tyagi leads the regenerative medicine protocol design at Stem Cell Cure India, overseeing stem cell sourcing, lab processing, and treatment planning for patients — including those travelling from Australia for stem cell injection treatment.
Dr. Singh brings over three decades of clinical experience in general medicine and surgery, supporting the overall health evaluation of patients — including baseline assessments for kidney disease patients — before and during their stem cell therapy journey at Stem Cell Cure India.
Mesenchymal Stem Cells (MSCs) are studied for their potential to reduce lung inflammation, support tissue repair, and improve markers of lung function in certain chronic respiratory conditions. Cells are typically administered via intravenous infusion under medical supervision. This approach is explored as a complement to — not a replacement for — standard pulmonology treatment such as bronchodilators, oxygen therapy, or antifibrotic medication where prescribed.
| Neuro Applications | Ortho Applications | Vascular Applications | Other Applications |
|---|---|---|---|
| Spinal Cord Injury | Avascular Necrosis | Optic Nerve Injury | Diabetes |
| Cerebral Palsy | Knee Cartilage Damage | Retinitis Pigmentosa | Chronic Kidney Disease |
| Autism | Rheumatoid Arthritis | Macular Degeneration | Chronic Liver Disease |
| Motor Neuron Disease | Non-Union Fracture | Peripheral Arterial Disease | Muscular Dystrophy |
Suitability depends on your specific condition and its stage. Before you travel, our team reviews:
StemCellCure administers stem cell therapy as a medical practice under qualified specialist supervision, after individual case evaluation. It is not FDA-approved and results vary by patient and condition.
In most cases, yes, since evaluation and administration are done in person in Delhi NCR. For patients who cannot travel, we can discuss whether treatment at a partner hospital closer to home is possible.
Cost depends on the condition and treatment plan required. Contact us for a personalised quote after sharing your medical reports
Yes. Once treatment is confirmed, we provide the invitation and supporting documents needed to apply for a Medical Visa.
